ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.

Clinical trial NCT00272064 · COMPLETED

Trial details

NCT number: NCT00272064
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-10-01
Primary completion: 2008-05-01
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.